HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines.

Abstract
In this study the in vitro antitumor activity of a series of 20 colchicine analogues was tested and compared with colchicine and thiocolchicine on three different human cancer cell lines, two of which express the multidrug-resistance (MDR) phenotype. At concentrations from 1 nM to 100 microM, all compounds tested inhibited cancer cell proliferation. The IC50 values indicate that the three fluorinated analogues were the most active compounds, with a similar decreasing order of potency (IDN 5005 > IDN 5079 > IDN 5080) on the two MDR-expressing cell lines, whereas thiocolchicine was the most effective compound on the MDR-negative MDA-MB 231 cells. A strong correlation (r = 0.94; P = 0.004) was found between IC50 values obtained using the two MDR-positive cell lines. Conversely, IC50 values obtained in MDA-MB 231 cells did not show a significant correlation with MDR-positive cell lines, thereby suggesting some difference in the antiproliferative mechanism(s) of colchicine analogues. Cell cycle analysis of the most active analogues in breast cancer cells showed a relationship between cell cycle blocking activity and growth inhibition. The most active agents on the MDR-positive MCF7 ADRr cell line, after 24 h of culture, in terms of cell cycle blocking activity were the three fluorinated analogues. Interestingly, after 72 h, when the cell cycle block subsided, a consistent amount of DNA fragmentation was evident. The extent of cell cycle block, measured as the G2/G1 ratio, was significantly correlated with the apoptosis rate expressed as a percentage of DNA fragmentation on both cell lines, thereby suggesting that a large number of blocked cells underwent the apoptotic pathway.
AuthorsR De Vincenzo, G Scambia, C Ferlini, M Distefano, P Filippini, A Riva, E Bombardelli, D Pocar, M L Gelmi, P Benedetti Panici, S Mancuso
JournalAnti-cancer drug design (Anticancer Drug Des) Vol. 13 Issue 1 Pg. 19-33 (Jan 1998) ISSN: 0266-9536 [Print] United States
PMID9474240 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Growth Inhibitors
  • Fluorine
  • thiocholchicine
  • Colchicine
Topics
  • Antineoplastic Agents (chemistry, pharmacology)
  • Cell Cycle (drug effects)
  • Colchicine (analogs & derivatives, chemistry, pharmacology)
  • Drug Resistance, Multiple
  • Fluorine
  • Growth Inhibitors (pharmacology)
  • Humans
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: